Funding for this research was provided by:
Arvid Nilssons Fond
The Faculty of Health and Medical Science Research Foundation
Aase og Ejnar Danielsens Fond
Received: 10 June 2019
Accepted: 26 October 2019
First Online: 12 November 2019
Ethics approval and consent to participate
: The study protocol was approved by the Danish National Ethical Committee (02-268856) and Danish Medicines Agency (2612-2867), and complied with the Declaration of Helsinki. The study is registered in ClinicalTrials.gov (NCT01449032). The Good Clinical Practice Unit of the Capital Region, Denmark monitored the trial throughout the 3 years study period. All patients received oral and written information about the study and signed a written informed consent prior to inclusion.
: Not applicable.
: The authors declare that they have no competing interests.